Continuous Cardiovascular Monitoring And Recovery Intelligence
QuanBio develops predictive hemodynamic monitoring technologies that transform continuous vascular physiology into earlier insight across cardiac ICUs, open-heart surgery, heart and lung transplant recovery, cardiovascular intervention, and longitudinal care.
By combining cardiovascular science, biologically grounded AI, and longitudinal physiologic analysis, the platform enables earlier recognition of cardiovascular instability, impaired micro perfusion, intervention response, and evolving hemodynamic deterioration across clinical and research environments.
The company’s work spans longitudinal cardiovascular evidence generation, therapeutic response analysis, and physiologic monitoring for healthcare and pharmaceutical applications.
Earlier Insight Into Cardiovascular Change
of cardiovascular disease is influenced by earlier understanding and intervention
QuanBio combines physiologic signal analysis, intervention-linked cardiovascular data, and biologically grounded AI to support earlier recognition of cardiovascular instability and recovery stress across clinical care environments.
The platform enables continuous monitoring, intervention tracking, and longitudinal outcome analysis spanning hospitals, cardiac ICUs, transplant recovery, and cardiovascular research programs.
Where Hemodynamics Meets Longitudinal Physiology
QuanBio combines physiologic signal analysis, hemodynamic interpretation, and continuous cardiovascular computation to transform complex vascular signals into deeper understanding of arterial stiffness, vascular function, recovery dynamics, and evolving physiologic change across clinical, life-science, and research environments.
Continuous physiologic monitoring
Recovery and intervention tracking
Longitudinal real-world evidence generation
Beyond Episodic Snapshots.
Continuous Cardiovascular Assessment.
Waveform analysis supporting earlier recognition of cardiovascular instability and evolving physiologic deterioration
Built on longitudinal physiology, clinical collaboration, and intervention-linked cardiovascular data
Generating continuous cardiovascular evidence infrastructure for healthcare and pharmaceutical applications
QuanBio’s technologies support longitudinal characterization of cardiovascular recovery, therapeutic response, and evolving patient outcomes across intervention, rehabilitation, and high-acuity cardiovascular care.
By connecting continuous physiologic monitoring with outcome-linked cardiovascular data, the platform enables deeper insight into recovery trajectories, treatment response, and real-world cardiovascular outcomes across healthcare and pharmaceutical applications.
